Evidence map›Paper›PMID 38335231›Full record

ArticlePLOS global public health2024

Improving tuberculosis case detection through contact risk stratification by Xpert MTB/RIF Ultra and spatial parameters: Evaluation of an innovative active case finding strategy in Mozambique (Xpatial-TB).

Belén Saavedra, Dinis Nguenha, Laura de la Torre-Pérez, Edson Mambuque, Gustavo Tembe, Laura Oliveras, Matthew Rudd, Paulo Philimone, Benedita Jose, Juan Ignacio Garcia and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Belén SaavedraCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Dinis NguenhaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.ORCID https://orcid.org/0000-0001-9921-2609
Laura de la Torre-PérezCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Edson MambuqueCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Gustavo TembeCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.ORCID https://orcid.org/0000-0001-7241-0381
Laura OliverasAgència de Salut Pública de Barcelona, Barcelona, Catalonia, Spain.ORCID https://orcid.org/0000-0003-0033-7829
Matthew RuddDepartment of Mathematics and Computer Science, The University of the South, Sewanee, Tennessee, United States of America.
Paulo PhilimoneCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Benedita JoseNational Tuberculosis Control Programme, Maputo, Mozambique.
Juan Ignacio GarciaPopulation Health Program Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Neide GomesCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Shilzia MunguambeCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Helio ChiconelaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Milton NhanommbeCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Santiago IzcoSTD/HIV/Aids and Tuberculosis department, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
Sozinho AcacioCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Alberto L García-BasteiroCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.ORCID https://orcid.org/0000-0002-2038-5505
Manhiça Health Research Centre · MZHospital de Sant Pau · ESNational Directorate of Geology · MZNational University of Equatorial Guinea · GQSewanee: The University of the South · USTexas Biomedical Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prompt diagnosis is critical for tuberculosis (TB) control, as it enables early treatment which in turn, reduces transmission and improves treatment outcomes. We investigated the impact on TB diagnosis of introducing Xpert Ultra as the frontline diagnostic test, combined with an innovative active-case finding (ACF) strategy (based on Xpert Ultra semi-quantitative results and spatial parameters), in a semi-rural district of Southern Mozambique. From January-December 2018 we recruited incident TB-cases (index cases, ICs) and their household contacts (HCs). Recruitment of close community contacts (CCs) depended on IC´s Xpert Ultra results, and the population density of their area. TB-contacts, either symptomatic or people living with HIV, were asked to provide a spot sputum for lab-testing. Trends on TB case notification were compared to the previous years and to those of two districts in the south of the Maputo province (control area), using an interrupted time series analysis with and without control (CITS/ITS). A total of 1010 TB ICs (37.1% laboratory-confirmed) were recruited; 3165 HCs and 4730 CCs were screened for TB. Eighty-nine additional TB cases were identified through the ACF intervention (52.8% laboratory-confirmed). The intervention increased by 8.2% all forms of TB cases detected in 2018. Xpert Ultra trace positive results accounted for a high proportion of laboratory confirmations in the ACF cohort (51.1% vs 13.7% of those passively diagnosed). The Number Needed to Screen to find a TB case differed widely among HCs (55) and CCs (153). During the intervention period, a reversal of the previous negative trend in lab-confirmed case notifications was observed in the district. However, the CITS model did not show any statistically significant difference compared to the control area. Paediatric population benefited the most from the ACF strategy and HCs screening seemed an effective intervention to find microbiological confirmed cases in early stages of the disease.

Identifiers

PMID38335231
PMCPMC10857722
OpenAlexW4391677570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.